FDA Inspection 1305890 — Medrange Corporation

Medrange Corporation — FEI 3008786200

The FDA completed an inspection of Medrange Corporation on February 24, 2026 in Brea, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 24, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Brea, CA (United States)